Open AccessP1058: REAL‐WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST‐RUXOLITINIB DISCONTINUATION
Author(s) -
Passamonti F.,
Lou Y.,
Chevli M.,
Abraham P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847100.49572.31
Subject(s) - ruxolitinib , medicine , discontinuation , myelofibrosis , cytopenia , oncology , pediatrics , bone marrow